Researchers ‘extraordinarily optimistic’ about potential of CAR-T for pediatric brain cancer
Researchers hope to replicate the successes in pediatric acute lymphoblastic leukemia — among the most common pediatric cancers — by using chimeric antigen receptor T cells to treat brain and CNS tumors.
Comentarios